IndiaTickerLatest filing: General Updates - Nectar Lifesciences Limited
ObservedCompany dossier
Nectar Lifesciences
NSE:NECLIFE · ISIN INE023H01027
- Close
- ₹10.22 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Nectar Lifesciences
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹455 Cr · PAT ₹7.8 Cr.
Exchange XBRLLatest ownership: promoter group 51.84% and public 48.16% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Nectar Lifesciences Limited
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing General Updates - Nectar Lifesciences Limited
NSE · exchange filing
Observed
Source filing Nectar Lifesciences Ltd - 532649 - Update On Slump Sale
BSE · exchange filing
Observed
Source filing General Updates - Nectar Lifesciences Limited
NSE · exchange filing
Observed
Source filing Nectar Lifesciences Ltd - 532649 - Announcement under Regulation 30 (LODR)-Change in Registered Office Address
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹455 Cr
- Profit after tax
- ₹7.8 Cr
- EPS
- ₹0.35
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 51.84%
- Public
- 48.16%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL